Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed

preview_player
Показать описание
Samarth Kulkarni, Crispr Therapeutics CEO, joins 'Power Lunch' to discuss the hurdles to getting rare disease drugs through regulation, what consumers can look forward to in gene editing, and much more.
Рекомендации по теме
Комментарии
Автор

I would love for CRISPR to work on HSP (Hereditary Spastic Paraplegia)! I have SPG4. This would be a miracle for so many people!!!❤

brendalewis
Автор

Will there be a terapeutic vs the cancer virus hpv?

valmardon
Автор

Would like to know if there is anything for Muscular Dystrophy?? DMD...

mamtharajiv
Автор

PLEASE PLEASE work on total intestinal agangliosis

mariealmeter
Автор

Is the cost of this treatment with CRISPR going to be paid for by insurance and Medicare?

sammyvh
Автор

Only $2M for the sickle cell treatment. Kinda dystopian.

Mostly_bad
Автор

We've heard all this crap before.... They're always 10 to 15 years away, 10 to 15 years away, 10 to 15 years away... They've been saying this crap for the last 30 years. I for one am not impressed.

slimcat
Автор

Another game changer that wont change anything.

saellenx
Автор

I would be happy if they can health me

CharlieKelly-ubqw
Автор

When it'll available for all people who r suffering from SCD & THALASSEMIA

indiancitizen
Автор

Anything being developed for severe Autism in children ?

muraliAnumolu
Автор

That ceo is a crock! He insisting shares like there is no tomorrow !

amostageer
Автор

Social and ethical aspects are critical when this tech is urtilized. Good thing to remember is that getting therapy or medication for rare genetic diseases will mean that it will help your own descendants too! If helping others does not motivate so much😂

edmanQ
Автор

Merge, motoru normal ebyne șoferu e obosyt😮😅

far
Автор

They don't even have a cure for the common cold but your gonna let them edit your DNA😂

Anthony-djnd